---
schema_version: "secwatch.filing_event.v1"
accession: "0000914475-22-000035"
form_type: "8-K"
ticker: "NBIX"
cik: "0000914475"
company_name: "NEUROCRINE BIOSCIENCES INC"
filed_at: "2022-06-01T23:59:59+00:00"
generated_at: "2026-06-25T05:42:56.871430+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Neurocrine repurchases $31.4M of 2.25% Convertible Notes due 2024 for $41.5M

## Summary
- Repurchased ~$31.4M principal of 2024 Convertible Notes for ~$41.5M including accrued interest.
- Transactions entered on May 31, 2022; closing expected June 2, 2022.
- Repurchases are in addition to those disclosed in May 25, 2022 Form 8-K.
- Company notes repurchases could affect common stock market price.

## SEC filing metadata
- accession: 0000914475-22-000035
- form_type: 8-K
- ticker: NBIX
- cik: 0000914475
- company_name: NEUROCRINE BIOSCIENCES INC
- filed_at: 2022-06-01T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/914475/000091447522000035/0000914475-22-000035-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/914475/000091447522000035/nbix-20220531.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000914475-22-000035
- JSON: https://secwatch.observer/filing/0000914475-22-000035.json
- Plain text: https://secwatch.observer/filing/0000914475-22-000035.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.